Alpha Lipoic Acid (ALA) and R-ALA for use for treatment of coronaviruses and viral infections

Class [5]
Pharmaceutical Products

Pharmaceutical drugs;Pharmaceutical for the treatment of erectile dysfunction;Pharmaceutical preparations;Pharmaceutical preparations acting on the central nervous system;Pharmaceutical preparations and substances;Pharmaceutical preparations and substances for use in urology;Pharmaceutical preparations and substances with analgesic properties;Pharmaceutical preparations and substances with anti-inflammatory properties;Pharmaceutical preparations for activating cellular function;Pharmaceutical preparations for human use;Pharmaceutical preparations for immunity adjustment;Pharmaceutical preparations for inducing erections;Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension;Pharmaceutical preparations for inhalers;Diabetic fruit juice beverages adapted for medical purposes;Diabetic fruit juice beverages adapted for medical use;Pharmaceutical agents affecting metabolism;Pharmaceutical for the treatment of erectile dysfunction;Pharmaceutical preparations and substances;Pharmaceutical preparations and substances for use in urology;Pharmaceutical preparations and substances with analgesic properties;Pharmaceutical preparations and substances with anti-inflammatory properties;Pharmaceutical preparations for activating cellular function;Pharmaceutical preparations for inducing erections.